Posted on November 6, 202511/6/25
EVERSANA Named AI Company of the Year by BioTech Breakthrough
Posted on November 6, 202511/6/25
EVERSANA named AI Company of the Year by BioTech Breakthrough
Posted on October 30, 202510/30/25
Changing Faces – Agency, investor, and legal hires – August and September 2025 Sales & Marketing
Posted on October 24, 202510/24/25
OWP Pharmaceuticals Selects EVERSANA to Support U.S. Launch of SUBVENITE® (lamotrigine) Oral Suspension
Posted on October 23, 202510/23/25
IndustryBRIEFS
Posted on October 21, 202510/21/25
What personalized, measurable MSL engagement could mean to pharma
Posted on October 17, 202510/17/25
4 ads that prove pharma marketers can break through despite regulations
Posted on October 17, 202510/17/25
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA
Posted on October 16, 202510/16/25
Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
Posted on October 16, 202510/16/25